KaloBios Liquidating Assets After Multiple Failed Trial Attempts

KaloBios Pharmaceuticals selling assets and winding down operations as it sees no other way to obtain further financing in the time allotted. Its shares plunged 79% after hours on Oct. 13 for a total 98 percent plunge from its 52 week high.